Liquidia Corp (NASDAQ: LQDA) is 51.05% higher on its value in year-to-date trading and has touched a low of $8.26 and a high of $19.41 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The LQDA stock was last observed hovering at around $15.1 in the last trading session, with the day’s gains setting it 1.5%.
Currently trading at $16.6, the stock is 21.62% and 10.86% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.86 million and changing 9.93% at the moment leaves the stock 23.44% off its SMA200. LQDA registered 41.16% gain for a year compared to 6-month gain of 28.78%. The firm has a 50-day simple moving average (SMA 50) of $14.9746 and a 200-day simple moving average (SMA200) of $13.44825.
The stock witnessed a 26.04% loss in the last 1 month and extending the period to 3 months gives it a 24.91%, and is 14.40% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.16% over the week and 5.78% over the month.
Liquidia Corp (LQDA) has around 157 employees, a market worth around $1.42B and $14.14M in sales. Profit margin for the company is -903.80%. Distance from 52-week low is 100.97% and -14.48% from its 52-week high. The company has generated returns on investments over the last 12 months (-80.21%).
with sales reaching $3.9M over the same period.The EPS is expected to grow by 7.31% this year, but quarterly earnings will post 184.71% year-over-year. Quarterly sales are estimated to grow 6.59% in year-over-year returns.
Liquidia Corp (LQDA) Top Institutional Holders
228.0 institutions hold shares in Liquidia Corp (LQDA), with institutional investors hold 75.32% of the company’s shares. The shares outstanding are 85.30M, and float is at 68.83M with Short Float at 31.02%. Institutions hold 65.04% of the Float.
The top institutional shareholder in the company is CALIGAN PARTNERS LP with over 10.36 million shares valued at $124.33 million. The investor’s holdings represent 13.5551% of the LQDA Shares outstanding. As of 2024-06-30, the second largest holder is PATIENT SQUARE CAPITAL LP with 7.18 million shares valued at $86.19 million to account for 9.3968 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 4.24 million shares representing 5.5481% and valued at over $50.89 million, while VANGUARD GROUP INC holds 4.4505 of the shares totaling 3.4 million with a market value of $40.82 million.
Liquidia Corp (LQDA) Insider Activity
The most recent transaction is an insider sale by Schundler Russell, the company’s General Counsel. SEC filings show that Schundler Russell sold 7,836 shares of the company’s common stock on Jul 14 ’25 at a price of $14.28 per share for a total of $0.11 million. Following the sale, the insider now owns 0.58 million shares.
Liquidia Corp disclosed in a document filed with the SEC on Jul 14 ’25 that Saggar Rajeev (Chief Medical Officer) sold a total of 5,327 shares of the company’s common stock. The trade occurred on Jul 14 ’25 and was made at $14.28 per share for $76070.0. Following the transaction, the insider now directly holds 0.27 million shares of the LQDA stock.
Still, SEC filings show that on Jul 14 ’25, Moomaw Scott (Chief Commercial Officer) disposed off 4,797 shares at an average price of $14.28 for $68501.0. The insider now directly holds 223,231 shares of Liquidia Corp (LQDA).
